Here is an excerpt from the Youngevity clinical research study performed by Clemson University Institute of Nutraceutical Research.

Go to the Youngevity Clemson Report for the Comprehensive Report

The INR is a national leader in nutritional research and one of the most highly regarded organizations in the field of phytonutrients, vitamins and minerals. The goals of the INR are to develop greater confidence in product quality, effectiveness, and enhance consumer demand for quality nutraceutical products.

The clinical studies were performed to identify the potential benefits of Youngevity’s signature core products, Beyond Tangy Tangerine® and Ultimate Classic®. Youngevity’s mission was to truly understand and clinically substantiate the health promoting benefits of these two products. Individually, each product targets specific areas, needs, and nutritional deficiencies of the body.

Multiple studies were recommended by Clemson University scientists to provide a comprehensive evaluation of the Youngevity® products. Specific biomarkers were chosen to study in the areas of safety, inflammation, and when Beyond Tangy Tangerine® and Ultimate Classic® were administered to cancer cell cultures.

Youngevity® Clinical Research Study Highlights:

  • Dietary supplement safety is the most highly regarded aspect of any of the Youngevity® various products and has become synonymous with the Youngevity® name and brand. Although Youngevity® only uses nutrients that are absolutely needed by the body and in forms that are highly bioavailable, Youngevity® felt it was important to show empirically the range and degree of safety through looking at (3) factors – Genotoxicity, Anti-Genotoxicity, and Anti-Mutagenicity. The results of the experiments showed that Beyond Tangy Tangerine® and Ultimate Classic® at various concentrations did not show any genotoxicity.
  • When Beyond Tangy Tangerine® and Ultimate Classic® were administered to healthy human cell lines; they did not induce or create any inflammatory response in levels above and below the recommended dosage. Beyond Tangy Tangerine® and Ultimate Classic® showed inflammation protective properties and heightened the body’s protective responses to possible inflammation.
  • When Beyond Tangy Tangerine® and Ultimate Classic® were administered to healthy human colon cells; there was no significant death of healthy human cells compared to cancerous colon cells.
  • Ultimate Classic® killed
    • 95% of cancerous colon cells,
    • 65% of cancerous liver cells,
    • 65% of cancerous stomach cells, and
    • 30% of cancerous breast cells.
  • Beyond Tangy Tangerine® killed
    • 60% of cancerous colon cells,
    • 65% of cancerous liver cells,
    • 65% of cancerous stomach cells, and
    • 30% of cancerous breast cells.
  • Beyond Tangy Tangerine® and Ultimate Classic® both exhibited efficient inhibition on proliferation of cancerous cells at the recommended dosage levels. Both products showed there was inhibition of the growth of more cancerous cells,

We hope you found this information useful and if we can be of assistance in any way, please contact us or feel free to call Peggy at 515-223-2822.